Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals

被引:0
|
作者
Valérie Martinez
Thi Dieu Ngan TA
Zahra Mokhtari
Marguerite Guiguet
Patrick Miailhes
Marc-Antoine Valantin
Fréderic Charlotte
Philippe Bertheau
Jean-Michel Molina
Christine Katlama
Eric Caumes
机构
关键词
Open Access; Base Case; Business Model; Long Term Evolution; Hepatic Steatosis;
D O I
10.1186/gb-2012-13-3-123
中图分类号
学科分类号
摘要
In this paper we evaluate the economic gains of a joint deployment of femtocells and macrocells for the provision of Long Term Evolution (LTE) mobile broadband services in urban environments. Frequency bands of 2.6 GHz and 900 MHz are analyzed and different parameters related to the business model are considered for a 30% market share operator. Results show important benefits for the base case where the service is offered to fixed-broadband clients, up to 75%, for small bandwidths. It results feasible to attribute subscriber loop costs to the radio access network (RAN) costs, so that the service could be offered to non fixed-broadband clients, in both cases of closed access and open access femtocells. However, initial savings result notably reduced, up to 50% less than in the base case if closed access is adopted and up to 13% less for open access. Site reuse reduces the initial savings only in 3%.
引用
收藏
相关论文
共 50 条
  • [1] Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
    Valrie Martinez
    Thi Dieu Ngan TA
    Zahra Mokhtari
    Marguerite Guiguet
    Patrick Miailhes
    Marc-Antoine Valantin
    Frderic Charlotte
    Philippe Bertheau
    Jean-Michel Molina
    Christine Katlama
    Eric Caumes
    BMC Research Notes, 5 (1)
  • [2] Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
    Valérie Martinez
    Thi Dieu Ngan TA
    Zahra Mokhtari
    Marguerite Guiguet
    Patrick Miailhes
    Marc-Antoine Valantin
    Fréderic Charlotte
    Philippe Bertheau
    Jean-Michel Molina
    Christine Katlama
    Eric Caumes
    Genome Biology, 13 (3)
  • [3] Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors
    Bani-Sadr, F
    Carrat, F
    Bedossa, P
    Piroth, L
    Cacoub, P
    Perronne, C
    Degott, C
    Pol, S
    AIDS, 2006, 20 (04) : 525 - 531
  • [4] ANTIRETROVIRALS REDUCE RIBAVIRIN EXPOSURE IN HIV-HCV COINFECTED PATIENTS
    Quioc, Jean-Jacques
    Jullien, Vincent
    Mallet, Vincent
    Nalpas, Bertrand
    Pol, Stanislas
    HEPATOLOGY, 2008, 48 (04) : 874A - 874A
  • [5] Contributions to hepatic fibrosis in HIV-HCV coinfected and HCV monoinfected patients
    Monto, Alexander
    Kakar, Sanjay
    Dove, Lorna M.
    Bostrom, Alan
    Miller, Erica L.
    Wright, Teresa L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (07): : 1509 - 1515
  • [6] Influence of antiretroviral therapy in the progression of steatosis in HIV/HCV coinfected patients
    Mussini, C
    Borghi, V
    Bellelli, S
    Angeletti, C
    Sabbatini, F
    Prati, F
    Mongiardo, N
    Esposito, R
    JOURNAL OF HEPATOLOGY, 2005, 42 : 214 - 214
  • [7] A new variable influencing HCV-related liver disease in HIV-HCV coinfected individuals?
    Stapleton, Jack
    GASTROENTEROLOGY, 2007, 133 (06) : 2042 - 2045
  • [8] Hepatic steatosis in HIV-HCV coinfected patients in France:: comparison with HCV monoinfected patients matched for body mass index and HCV genotype
    Castera, L.
    Loko, M. A.
    Le Bail, B.
    Coffie, P.
    De Ledinghen, V.
    Trimoulet, P.
    Winnock, M.
    Dabis, F.
    Neau, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (11-12) : 1489 - 1498
  • [9] A Prospective Study of The Association of Body Morphometry With Hepatic Steatosis and Fibrosis in HIV-HCV Coinfected Patients
    Awad, Chadi M.
    Nguyen, Tuyet A.
    Puri, Puneet
    Sanyal, Arun J.
    Luketic, Velimir A.
    Stravitz, R. Todd
    Siddique, Mohammad S.
    Bouneva, Iliana
    Sterling, Richard K.
    HEPATOLOGY, 2013, 58 : 1305A - 1306A
  • [10] Hepatitis C virus (HCV) diversity in HIV-HCV coinfected persons initiating antiretroviral therapy.
    Blackard, JT
    HEPATOLOGY, 2003, 38 (04) : 464A - 464A